Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (3) , 319-324
- https://doi.org/10.1016/0959-8049(93)90376-q
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung CancerNew England Journal of Medicine, 1991
- Chemotherapy in small cell lung cancer: a consensus reportLung Cancer, 1989
- Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the UrotheliumNew England Journal of Medicine, 1988
- EFFECT OF GRANULOCYTE COLONY STIMULATING FACTOR ON NEUTROPENIA INDUCED BY CYTOTOXIC CHEMOTHERAPYThe Lancet, 1988
- Empirical Antimicrobial Therapy for Febrile Granulocytopenic Cancer Patients: Lessons from Four EORTC TrialsPublished by Springer Nature ,1988
- Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancerBritish Journal of Cancer, 1987
- Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapyEuropean Journal of Cancer and Clinical Oncology, 1984
- Management of hematologic and infectious complications of intensive induction therapy for small cell carcinoma of the lungThe American Journal of Medicine, 1983
- Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute LeukemiaAnnals of Internal Medicine, 1966
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958